Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T M Perl

Showing results (41-50 of 50) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 50 results.
Critical Care Medicine|June 1, 1995
A second large controlled clinical study of E5, a monoclonal antibody to endotoxin: results of a prospective, multicenter, randomized, controlled trial. The E5 Sepsis Study GroupR C Bone, R A Balk, A M Fein, et al.
Infection Control and Hospital Epidemiology|October 26, 1999
Requirements for infrastructure and essential activities of infection control and epidemiology in out-of-hospital settings: a consensus panel report. Association for Professionals in Infection Control and Epidemiology and Society for Healthcare Epidemiology of AmericaC Friedman, M Barnette, A S Buck, et al.
American Journal of Infection Control|October 8, 1999
Requirements for infrastructure and essential activities of infection control and epidemiology in out-of-hospital settings: a Consensus Panel reportC Friedman, M Barnette, A S Buck, et al.
Lancet (London, England)|August 26, 1998
Learning and memory difficulties after environmental exposure to waterways containing toxin-producing Pfiesteria or Pfiesteria-like dinoflagellatesL M Grattan, D Oldach, T M Perl, et al.
JAMA|May 18, 1999
Anthrax as a biological weapon: medical and public health management. Working Group on Civilian BiodefenseT V Inglesby, D A Henderson, J G Bartlett, et al.
Infection Control and Hospital Epidemiology|April 21, 2010
Quantitative analysis and molecular fingerprinting of methicillin-resistant Staphylococcus aureus nasal colonization in different patient populations: a prospective, multicenter studyL A Mermel, S J Eells, M K Acharya, et al.
Annals of Surgery|February 15, 2001
Surveillance strategies and impact of vancomycin-resistant enterococcal colonization and infection in critically ill patientsC W Hendrix, J M Hammond, S M Swoboda, et al.
JAMA|March 7, 2001
Botulinum toxin as a biological weapon: medical and public health managementS S Arnon, R Schechter, T V Inglesby, et al.
JAMA|June 21, 2001
Tularemia as a biological weapon: medical and public health managementD T Dennis, T V Inglesby, D A Henderson, et al.
JAMA|May 12, 2000
Plague as a biological weapon: medical and public health management. Working Group on Civilian BiodefenseT V Inglesby, D T Dennis, D A Henderson, et al.
Pageof 5

Showing results (41-50 of 50) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 50 results.
Critical Care Medicine|June 1, 1995
A second large controlled clinical study of E5, a monoclonal antibody to endotoxin: results of a prospective, multicenter, randomized, controlled trial. The E5 Sepsis Study GroupR C Bone, R A Balk, A M Fein, et al.
Infection Control and Hospital Epidemiology|October 26, 1999
Requirements for infrastructure and essential activities of infection control and epidemiology in out-of-hospital settings: a consensus panel report. Association for Professionals in Infection Control and Epidemiology and Society for Healthcare Epidemiology of AmericaC Friedman, M Barnette, A S Buck, et al.
American Journal of Infection Control|October 8, 1999
Requirements for infrastructure and essential activities of infection control and epidemiology in out-of-hospital settings: a Consensus Panel reportC Friedman, M Barnette, A S Buck, et al.
Lancet (London, England)|August 26, 1998
Learning and memory difficulties after environmental exposure to waterways containing toxin-producing Pfiesteria or Pfiesteria-like dinoflagellatesL M Grattan, D Oldach, T M Perl, et al.
JAMA|May 18, 1999
Anthrax as a biological weapon: medical and public health management. Working Group on Civilian BiodefenseT V Inglesby, D A Henderson, J G Bartlett, et al.
Infection Control and Hospital Epidemiology|April 21, 2010
Quantitative analysis and molecular fingerprinting of methicillin-resistant Staphylococcus aureus nasal colonization in different patient populations: a prospective, multicenter studyL A Mermel, S J Eells, M K Acharya, et al.
Annals of Surgery|February 15, 2001
Surveillance strategies and impact of vancomycin-resistant enterococcal colonization and infection in critically ill patientsC W Hendrix, J M Hammond, S M Swoboda, et al.
JAMA|March 7, 2001
Botulinum toxin as a biological weapon: medical and public health managementS S Arnon, R Schechter, T V Inglesby, et al.
JAMA|June 21, 2001
Tularemia as a biological weapon: medical and public health managementD T Dennis, T V Inglesby, D A Henderson, et al.
JAMA|May 12, 2000
Plague as a biological weapon: medical and public health management. Working Group on Civilian BiodefenseT V Inglesby, D T Dennis, D A Henderson, et al.
Pageof 5